Halozyme Therapeutics | HALO - Umlaufvermögen





Umlaufvermögen Veränderung Datum
Acadia Pharmaceuticals USD 1.22B 128.53M 2026-06
Agios Pharmaceuticals USD 717.67M 117.18M 2026-06
Alnylam Pharmaceuticals USD 5.11B 492.49M 2026-09
Amarin USD 612.88M 10.12M 2026-09
Amgen USD 34.96B 3.49B 2026-06
Baxter International USD 6.83B 163M 2026-09
Cara Therapeutics USD 25.33M 6.21M 2026-03
Cytokinetics USD 1.21B 369.02M 2026-06
DBV Technologies USD 189.6M 12.3M 2026-09
Eli Lilly USD 65.26B 591M 2026-09
Halozyme Therapeutics USD 933.02M 70.01M 2026-06
Intrexon USD 23.72M 45.04M 2024-06
Ionis Pharmaceuticals USD 2.49B 446.73M 2026-06
MannKind USD 245.71M 5.45M 2026-06
Minerva Neurosciences USD 83.1M 70.08M 2025-12
Nektar Therapeutics USD 589.04M 322.77M 2026-03
Pfizer USD 41.36B 1.46B 2026-06
Rigel Pharmaceuticals USD 214.93M 39.53M 2025-09
United Therapeutics USD 3.48B 611.7M 2026-06
Vanda Pharmaceuticals USD 347.26M 20.23M 2025-12